<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1308" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1308/" /><meta name="ncbi_pagename" content="Familial Lipoprotein Lipase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Familial Lipoprotein Lipase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Familial Lipoprotein Lipase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/06/22" /><meta name="citation_author" content="John R Burnett" /><meta name="citation_author" content="Amanda J Hooper" /><meta name="citation_author" content="Robert A Hegele" /><meta name="citation_pmid" content="20301485" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1308/" /><meta name="citation_keywords" content="Familial LPL Deficiency" /><meta name="citation_keywords" content="Type I Hyperlipoproteinemia" /><meta name="citation_keywords" content="Familial Chylomicronemia Syndrome" /><meta name="citation_keywords" content="Familial LPL Deficiency" /><meta name="citation_keywords" content="Lipoprotein lipase" /><meta name="citation_keywords" content="LPL" /><meta name="citation_keywords" content="Familial Lipoprotein Lipase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Familial Lipoprotein Lipase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="John R Burnett" /><meta name="DC.Contributor" content="Amanda J Hooper" /><meta name="DC.Contributor" content="Robert A Hegele" /><meta name="DC.Date" content="2017/06/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1308/" /><meta name="description" content="Familial lipoprotein lipase (LPL) deficiency usually presents in childhood and is characterized by very severe hypertriglyceridemia with episodes of abdominal pain, recurrent acute pancreatitis, eruptive cutaneous xanthomata, and hepatosplenomegaly. Clearance of chylomicrons from the plasma is impaired, causing triglycerides to accumulate in plasma and the plasma to have a milky (lactescent or lipemic) appearance. Symptoms usually resolve with restriction of total dietary fat to ≤20 g/day." /><meta name="og:title" content="Familial Lipoprotein Lipase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Familial lipoprotein lipase (LPL) deficiency usually presents in childhood and is characterized by very severe hypertriglyceridemia with episodes of abdominal pain, recurrent acute pancreatitis, eruptive cutaneous xanthomata, and hepatosplenomegaly. Clearance of chylomicrons from the plasma is impaired, causing triglycerides to accumulate in plasma and the plasma to have a milky (lactescent or lipemic) appearance. Symptoms usually resolve with restriction of total dietary fat to ≤20 g/day." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1308/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/lpl/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1308/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AE69CE040F0F10000000002D90101.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1308_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1308_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fmf/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1308_"><span class="title" itemprop="name">Familial Lipoprotein Lipase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Familial LPL Deficiency</div><p class="contrib-group"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA, <span itemprop="author">Amanda J Hooper</span>, PhD, and <span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP.</p><a data-jig="ncbitoggler" href="#__NBK1308_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1308_ai__"><div class="contrib half_rhythm"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@ttenrub.nhoj" class="oemail">ua.vog.aw.htlaeh@ttenrub.nhoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Amanda J Hooper</span>, PhD<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@repooh.adnama" class="oemail">ua.vog.aw.htlaeh@repooh.adnama</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP<div class="affiliation small">Departments of Medicine and Biochemistry<br />Schulich School of Medicine and Robarts Research Institute<br />Western University<br />London, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.strabor@elegeh" class="oemail">ac.strabor@elegeh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 12, 1999</span>; Last Update: <span itemprop="dateModified">June 22, 2017</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="lpl.Summary" itemprop="description"><h2 id="_lpl_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Familial lipoprotein lipase (LPL) deficiency usually presents in childhood and is characterized by very severe hypertriglyceridemia with episodes of abdominal pain, recurrent acute pancreatitis, eruptive cutaneous xanthomata, and hepatosplenomegaly. Clearance of chylomicrons from the plasma is impaired, causing triglycerides to accumulate in plasma and the plasma to have a milky (lactescent or lipemic) appearance. Symptoms usually resolve with restriction of total dietary fat to &#x02264;20 g/day.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of LPL deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LPL</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is based on medical nutrition therapy to maintain plasma triglyceride concentration below 1000 mg/dL. Maintenance of triglyceride levels below 2000 mg/dL prevents recurrent abdominal pain. Restriction of dietary fat to &#x02264;20 g/day or 15% of a total energy intake is usually sufficient to reduce plasma triglyceride concentration and to keep the individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency free of symptoms. An acute pancreatitis episode is treated with standard care.</p><p><i>Prevention of secondary complications</i>: Prevention of recurrent acute pancreatitis decreases the risk of developing diabetes mellitus.</p><p><i>Surveillance</i>: Monitoring of plasma triglycerides.</p><p><i>Agents/circumstances to avoid:</i> Agents known to increase endogenous triglyceride concentration such as alcohol, oral estrogens, diuretics, isotretinoin, glucocorticoids, selective serotonin reuptake inhibitors, and beta-adrenergic blocking agents; fish oil supplements are contraindicated because they contribute to chylomicron levels.</p><p><i>Pregnancy management</i>: For pregnant women with LPL deficiency, extreme dietary fat restriction to &#x0003c;2 g/day during the second and third trimesters of pregnancy with close monitoring of plasma triglyceride concentration is recommended.</p><p><i>Other</i>: The lipid-lowering drugs that are used to treat other disorders of lipid metabolism are not effective in individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Familial LPL deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="lpl.Diagnosis"><h2 id="_lpl_Diagnosis_">Diagnosis</h2><div id="lpl.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Familial lipoprotein lipase (LPL) deficiency <b>should be suspected</b> in individuals (particularly those age &#x0003c;40 years) with the following clinical and supportive laboratory findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Recurrent acute pancreatitis</div></li><li class="half_rhythm"><div>Eruptive cutaneous xanthomata</div></li><li class="half_rhythm"><div>Hepatosplenomegaly</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Impaired clearance of chylomicrons from plasma causing the plasma to have a milky (lactescent or lipemic) appearance</div></li><li class="half_rhythm"><div>Plasma triglyceride concentrations greater than 2000 mg/dL in the untreated state, regardless of fasting status</div></li></ul></div><div id="lpl.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of LPL deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LPL</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1308/table/lpl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figlplTmoleculargenetictestingusedin" rid-ob="figoblplTmoleculargenetictestingusedin">Table 1</a>).</p><p>A consensus diagnostic algorithm has been published [<a class="bk_pop" href="#lpl.REF.stroes.2017.1">Stroes et al 2017</a>] (see <a href="http://www.sciencedirect.com/science/article/pii/S1567568816300502" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Figure 3</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>LPL</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LPL</i> and other genes of interest for the chylomicronemia syndrome (see <a href="#lpl.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="lpl.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Familial Lipoprotein Lipase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1308/table/lpl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lpl.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>LPL</i></td><td headers="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~97%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_lpl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lpl.TF.1.1"><p class="no_margin">See <a href="/books/NBK1308/#lpl.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="lpl.TF.1.2"><p class="no_margin">See <a href="#lpl.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="lpl.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="lpl.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#lpl.REF.brunzell.2001">Brunzell &#x00026; Deeb [2001]</a>, <a class="bk_pop" href="#lpl.REF.gilbert.2001.25">Gilbert et al [2001]</a></p></div></dd><dt>5. </dt><dd><div id="lpl.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="lpl.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#lpl.REF.brunzell.2001">Brunzell &#x00026; Deeb [2001]</a></p></div></dd></dl></div></div></div><p><b>Measurement of lipoprotein lipase enzyme activity.</b> Affected individuals have low or absent LPL enzyme activity in an assay system that contains either normal plasma or apolipoprotein C-II (apoC-II; a cofactor of LPL) and excludes hepatic lipase (HL). This assay is not routinely available and is generally only performed at specialist centers.</p><ul><li class="half_rhythm"><div>LPL enzyme activity can be assayed in plasma taken ten minutes following intravenous administration of heparin (60 U/kg body weight). The absence of LPL enzyme activity in postheparin plasma is diagnostic of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency.</div></li><li class="half_rhythm"><div>LPL enzyme activity may be assayed directly in biopsies of adipose tissue.</div></li></ul></div></div><div id="lpl.Clinical_Characteristics"><h2 id="_lpl_Clinical_Characteristics_">Clinical Characteristics</h2><div id="lpl.Clinical_Description"><h3>Clinical Description</h3><p>Familial lipoprotein lipase (LPL) deficiency usually presents in childhood with episodes of abdominal pain, recurrent acute pancreatitis, eruptive cutaneous xanthomata, and hepatosplenomegaly. Males and females are affected equally.</p><p>Approximately 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children develop symptoms before age one year and the majority develop symptoms before age ten years; however, some individuals present for the first time during pregnancy. The severity of symptoms correlates with the degree of chylomicronemia. Chylomicrons are large triglyceride-rich lipoprotein particles that appear in the circulation shortly after the ingestion of dietary fat; normally, they are cleared from plasma after an overnight fast. The degree of chylomicronemia in LPL deficiency varies by dietary fat intake.</p><p>The abdominal pain, which can vary from mildly bothersome to incapacitating, is usually mid-epigastric with radiation to the back. It may be diffuse and mimic an acute abdomen, often leading to unnecessary abdominal exploratory surgery. The pain probably results from chylomicronemia leading to pancreatitis.</p><p><a class="bk_pop" href="#lpl.REF.kawashiri.2005.6541">Kawashiri et al [2005]</a> reported that individuals with LPL deficiency can lead a fairly normal life on a diet very low in total fat content. The secondary complications of pancreatitis &#x02013; diabetes mellitus, steatorrhea, and pancreatic calcification &#x02013; are unusual in individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency and rarely occur before middle age. Pancreatitis in LPL deficiency may rarely be associated with total pancreatic necrosis and death.</p><p>About 50% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency have eruptive xanthomas, small yellow papules localized over the trunk, buttocks, knees, and extensor surfaces of the arms. Xanthomas are deposits of lipid in the skin that result from the extravascular phagocytosis of chylomicrons by macrophages. They can appear rapidly when plasma triglyceride concentration exceeds 2000 mg/dL and can sometimes regress if plasma triglyceride is normalized.</p><p>Xanthomas may become generalized. As a single lesion, they may be several millimeters in diameter; rarely, they may coalesce into plaques. They are usually not tender unless they occur at a site susceptible to repeated abrasion.</p><p>Hepatomegaly and splenomegaly often occur when plasma triglyceride concentrations are markedly increased. The organomegaly results from triglyceride uptake by macrophages, which become foam cells.</p><p>When triglyceride concentrations exceed 4000 mg/dL, the retinal arterioles and venules, and often the fundus itself, develop a pale pink color ("lipemia retinalis"), caused by light scattering by large chylomicrons. This coloration is reversible and vision is not affected.</p><p>Reversible neuropsychiatric findings, including mild dementia, depression, and memory loss, have also been reported with chylomicronemia [<a class="bk_pop" href="#lpl.REF.heilman.1974.67">Heilman &#x00026; Fisher 1974</a>, <a class="bk_pop" href="#lpl.REF.chait.1981.343">Chait et al 1981</a>].</p></div><div id="lpl.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>As most pathogenic <i>LPL</i> variants have been reported in individual case reports or small case series, reliable systematic correlation of <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> relationships is challenging. There are no known <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p></div><div id="lpl.Nomenclature"><h3>Nomenclature</h3><p>Familial LPL deficiency is the most common form of the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> chylomicronemia syndrome, which was formerly known as "type 1 hyperlipoproteinemia."</p></div><div id="lpl.Prevalence"><h3>Prevalence</h3><p>The prevalence of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency is approximately one in 1,000,000 in the general US population.</p><p>The disease has been described in all races. The prevalence is much higher in some areas of Quebec, Canada as a result of a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a>.</p><p>Consanguinity is observed in some families with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency caused by <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic <i>LPL</i> variants.</p></div></div><div id="lpl.Genetically_Related_Allelic_Disorder"><h2 id="_lpl_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>LPL</i>.</p><p><b>Mild lipid abnormalities not associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency</b> have been reported with common variants of <i>LPL</i>, such as the p.Asn291Ser <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. The p.Asn291Ser allele does not appear to have a <b>major</b> effect on plasma lipid concentration or on risk for coronary disease in the general population; however, it may be associated with hypertriglyceridemia in the presence of the <i>APOE</i> E2 allele, diabetes mellitus, familial combined hyperlipidemia, hepatic lipase (HL) deficiency, and <a href="/books/n/gene/gsd1/">glycogen storage disease type Ib</a>. It is possible that the association of the p.Asn291Ser allele with these disorders is only a reflection of the relatively high frequency of this allele in the general population. Nonetheless, the allele likely predisposes to mild hypertriglyceridemia, but is insufficient in the absence of a secondary factor to cause more severe hypertriglyceridemia.</p></div><div id="lpl.Differential_Diagnosis"><h2 id="_lpl_Differential_Diagnosis_">Differential Diagnosis</h2><p>Familial lipoprotein lipase (LPL) deficiency should be considered in young persons with the chylomicronemia syndrome, defined as abdominal pain, eruptive xanthomata, plasma triglyceride concentrations greater than 2000 mg/dL, and fasting lipemic plasma. However, the majority of individuals with chylomicronemia and plasma triglyceride concentration greater than 2000 mg/dL do not have <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency; rather, they have one of the more common genetic disorders of triglyceride metabolism (i.e., familial combined hyperlipidemia and monogenic familial hypertriglyceridemia). Hypertriglyceridemia can also be <a class="def" href="/books/n/gene/glossary/def-item/polygenic/">polygenic</a>, due to both <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> rare large-effect variants and accumulations of common rare small-effect variants in several genes and loci [<a class="bk_pop" href="#lpl.REF.hegele.2014.655">Hegele et al 2014</a>]. With such genetic predisposition, clinical expression of chylomicronemia typically requires the presence of secondary, non-genetic factors [<a class="bk_pop" href="#lpl.REF.brunzell.2001">Brunzell &#x00026; Deeb 2001</a>].</p><p>Secondary causes of hypertriglyceridemia include: diabetes mellitus; paraproteinemia and lymphoproliferative disorders; use of alcohol; and therapy with estrogen, glucocorticoids, selective serotonin reuptake inhibitors, atypical antipsychotic agents, isotretinoin, or certain antihypertensive agents. In one series of 123 individuals evaluated for marked hypertriglyceridemia, 110 had an acquired cause of hypertriglyceridemia combined with a common genetic form of hypertriglyceridemia, five had <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency, five had other rare genetic forms of hypertriglyceridemia, and three had an unknown cause [<a class="bk_pop" href="#lpl.REF.chait.1983.209">Chait &#x00026; Brunzell 1983</a>].</p><p>Other than LPL deficiency, the chylomicronemia syndrome may be caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in apolipoprotein C-II (<i>APOC2</i>), apolipoprotein A-V (<i>APOA5</i>), lipase maturation factor 1 (<i>LMF1</i>) or <i>GPIHBP1</i> (see <a class="figpopup" href="/books/NBK1308/table/lpl.T.genetic_causes_of_primary_monogeni/?report=objectonly" target="object" rid-figpopup="figlplTgeneticcausesofprimarymonogeni" rid-ob="figoblplTgeneticcausesofprimarymonogeni">Table 2</a>).</p><div id="lpl.T.genetic_causes_of_primary_monogeni" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genetic Causes of Primary Monogenic Chylomicronemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1308/table/lpl.T.genetic_causes_of_primary_monogeni/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lpl.T.genetic_causes_of_primary_monogeni_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene (Gene Product)</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homozygote Prevalence</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene Product Function</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Molecular Features</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Monogenic Variants</th><th id="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LPL</i><br />(LPL)</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~1 per million individuals <sup>1</sup></td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hydrolysis of triglycerides &#x00026; peripheral uptake of FFA</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe chylomicronemia in infancy or childhood</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely reduced or absent LPL enzyme activity</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95.0</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#lpl.REF.murthy.1996.101">Murthy et al [1996]</a>, <a class="bk_pop" href="#lpl.REF.jap.2003.122">Jap et al [2003]</a>, <a class="bk_pop" href="#lpl.REF.gotoda.2012.1">Gotoda et al [2012]</a>, <a class="bk_pop" href="#lpl.REF.mart_ncampos.2014.61">Mart&#x000ed;n-Campos et al [2014]</a></td></tr><tr><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APOC2</i> (apoC-II)</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 families reported</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Required cofactor of LPL</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe chylomicronemia in childhood or adolescence</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent or nonfunctional apoC-II</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.0</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#lpl.REF.gotoda.2012.1">Gotoda et al [2012]</a>, <a class="bk_pop" href="#lpl.REF.okubo.2015.148">Okubo et al [2015]</a></td></tr><tr><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPIHBP1</i> (GPI-HBP1)</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 families reported</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stabilizes binding of chylomicrons near LPL; supports lipolysis</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chylomicronemia in late adulthood</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent or defective GPI-HBP1</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.0</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#lpl.REF.beigneux.2009.956">Beigneux et al 2009</a>, <a class="bk_pop" href="#lpl.REF.gin.2012.2961">Gin et al [2012]</a></td></tr><tr><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APOA5</i> (apoA-V)</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Three families reported</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enhancer of LPL activity</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chylomicronemia in late adulthood</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent or defective apoA-V</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.6</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#lpl.REF.calandra.2006.122">Calandra et al [2006]</a>, <a class="bk_pop" href="#lpl.REF.nilsson.2011.15">Nilsson et al [2011]</a></td></tr><tr><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMF1</i> (LMF1)</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Two families reported</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chaperone molecule required for proper LPL folding and/or expression</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chylomicronemia in late adulthood</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent or defective LMF1</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.4</td><td headers="hd_h_lpl.T.genetic_causes_of_primary_monogeni_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#lpl.REF.p_terfy.2012.790">P&#x000e9;terfy [2012]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">From <a class="bk_pop" href="#lpl.REF.brahm.2015.352">Brahm &#x00026; Hegele [2015]</a>; reprinted by permission of Macmillan Publishers, Ltd.</p></div></dd><dt></dt><dd><div><p class="no_margin">apoA-V = apolipoprotein A-V; apoC-II = apolipoprotein C-II; FFA = free fatty acid; GPI-HBP1 = glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1; LMF1 = lipase maturation factor 1; LPL = lipoprotein lipase</p></div></dd><dt>1. </dt><dd><div id="lpl.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#lpl.REF.gotoda.2012.1">Gotoda et la [2012]</a></p></div></dd></dl></div></div></div><ul><li class="half_rhythm"><div><b>Familial apolipoprotein C-II (apoC-II) deficiency</b> (OMIM <a href="http://omim.org/entry/207750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">207750</a>). ApoC-II is a cofactor for LPL. Familial apoC-II deficiency is an extremely rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder that differs from <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency in that (1) symptoms generally develop at a later age (13-60 years) and (2) individuals may develop chronic pancreatic insufficiency with steatorrhea and insulin-dependent diabetes mellitus. The diagnosis is based on the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>APOC2</i>, on assay of plasma apoC-II concentration or activation of a purified LPL standard, and on gel electrophoresis of VLDL apolipoproteins. Infusion of normal plasma into an individual with familial apoC-II deficiency results in dramatic reduction of the plasma triglyceride concentration. Treatment is a low-fat diet throughout life.</div></li><li class="half_rhythm"><div><b>Familial apolipoprotein A-V deficiency</b> (OMIM <a href="http://omim.org/entry/144650" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">144650</a>). It has been suggested that apoA-V facilitates the interaction of endothelial heparan sulfate with apoC-II on triglyceride-rich lipoproteins and the interaction of apoC-II with LPL on the vascular endothelium. Several families with apoA-V deficiency have been reported to have severe hypertriglyceridemia. Biallelic large-effect <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants in <i>APOA5</i> can lead to <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> chylomicronemia syndrome, while <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers are predisposed to hypertriglyceridemia, but often demonstrate a normal clinical and biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the absence of secondary non-genetic factors.</div></li><li class="half_rhythm"><div><b>Familial lipase maturation factor 1 (LMF1) deficiency</b> (OMIM <a href="http://omim.org/entry/246650" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">246650</a>). LMF1 is a transmembrane protein localized to the endoplasmic reticulum involved in the maturation of both LPL and hepatic lipase (HL). One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>LMF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, had very low LPL activity, modestly low HL activity, and chylomicronemia [<a class="bk_pop" href="#lpl.REF.p_terfy.2007.1483">P&#x000e9;terfy et al 2007</a>].</div></li><li class="half_rhythm"><div><b>Familial glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) deficiency</b> (OMIM <a href="http://omim.org/entry/615947" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615947</a>). GPIHBP1 appears to be a binding site for LPL on the capillary endothelial surface, perhaps through binding with apoA-V [<a class="bk_pop" href="#lpl.REF.beigneux.2007.279">Beigneux et al 2007</a>]. Several individuals with GPIHBP1 deficiency have been described. Biallelic large-effect <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants of <i>GPIHBP1</i> can lead to <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> chylomicronemia syndrome, while <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers are predisposed to hypertriglyceridemia, but often demonstrate a normal clinical and biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the absence of secondary non-genetic factors. Recently, autoantibodies against GPIHBP1 were shown to cause chylomicronemia syndrome [<a class="bk_pop" href="#lpl.REF.beigneux.2017.1647">Beigneux et al 2017</a>].</div></li></ul></div><div id="lpl.Management"><h2 id="_lpl_Management_">Management</h2><div id="lpl.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> lipoprotein lipase (LPL) deficiency, measurement of plasma triglyceride concentration is recommended.</p><p>Consultation with a clinical geneticist and/or genetic counselor may also be considered.</p></div><div id="lpl.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Medical nutrition therapy.</b> Morbidity and mortality can be prevented by maintaining plasma triglyceride concentration at less than 2000 mg/dL; a good clinical goal is less than 1000 mg/dL [<a class="bk_pop" href="#lpl.REF.viljoen.2012.505">Viljoen &#x00026; Wierzbicki 2012</a>]. Restriction of dietary fat to no more than 20 g/day or 15% of total energy intake is usually sufficient to reduce plasma triglyceride concentration and to keep the individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency free of symptoms.</p><p>Medium-chain triglycerides may be used for cooking, as they are absorbed directly into the portal vein without becoming incorporated into chylomicron triglyceride.</p><p>The success of therapy depends on the individual's acceptance of the fat restriction, including both unsaturated and saturated fat. Note: Fish oil supplements, which are effective in disorders of excess hepatic triglyceride production, are not effective in LPL deficiency and are contraindicated (see <a href="#lpl.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>).</p><p>The enlarged liver and spleen can return to normal size within one week of lowering of triglyceride concentrations.</p><p>The xanthomas can clear over the course of weeks to months. Recurrent or persistent eruptive xanthomas indicate inadequate therapy.</p><p>Pancreatitis associated with the chylomicronemia syndrome is treated in the manner typical for other forms of pancreatitis.</p><ul><li class="half_rhythm"><div>Discontinuation of oral fat intake stops chylomicron triglyceride formation, and replacement with hypocaloric parenteral nutrition decreases VLDL triglyceride production.</div></li><li class="half_rhythm"><div>Administration of excess calories, as in hyperalimentation, is contraindicated in the acute state. The intravenous administration of lipid emulsions may lead to persistent or recurrent pancreatitis.</div></li></ul><p>If recurrent pancreatitis with severe hypertriglyceridemia occurs, total dietary fat intake needs to be reduced.</p></div><div id="lpl.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>See <a href="#lpl.Treatment_of_Manifestations">Treatment of Manifestations</a>.</p></div><div id="lpl.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Prevention of recurrent acute pancreatitis decreases the risk of developing diabetes mellitus. Fat malabsorption is very rare.</p></div><div id="lpl.Surveillance"><h3>Surveillance</h3><p>Plasma triglyceride levels need to be followed over time to evaluate the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual&#x02019;s success in following the very low-fat dietary recommendations. When the triglyceride level is above 1000 mg/dL, a fasting sample is not required for this evaluation. Other components of the lipid profile do not need to be routinely measured.</p><p>Affected individuals who develop abdominal pain need to contact their physician.</p></div><div id="lpl.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoidance of agents known to increase endogenous triglyceride concentration such as alcohol, oral estrogens, diuretics, isotretinoin, glucocorticoids, selective serotonin reuptake inhibitors, and beta-adrenergic blocking agents is recommended.</p><p>Fish oil supplements are contraindicated as they contribute to chylomicron levels.</p></div><div id="lpl.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate at-risk sibs during infancy. Early diagnosis and implementation of dietary fat intake restriction can prevent symptoms and related medical complications.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Measurement of plasma triglyceride concentration;</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known.</div></li></ul><p>See <a href="#lpl.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to evaluation of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="lpl.Pregnancy_Management"><h3>Pregnancy Management</h3><p>During pregnancy in a woman with LPL deficiency, extreme dietary fat restriction to less than two grams per day during the second and third trimester with close monitoring of plasma triglyceride concentration can result in delivery of a normal infant with normal plasma concentrations of essential fatty acids [<a class="bk_pop" href="#lpl.REF.alshali.2002.125">Al-Shali et al 2002</a>].</p><p>One woman with LPL deficiency delivered a normal child following a one-gram per day fat diet and treatment with gemfibrozil (600 mg/day) [<a class="bk_pop" href="#lpl.REF.tsai.2004.27">Tsai et al 2004</a>]. Despite concerns about the possibility of essential fatty acid deficiency in the newborn, normal essential fatty acids were found in cord blood, as were normal levels of fibrate metabolites.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="lpl.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><i>LPL</i> <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> is available in Europe and the US for the treatment of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency. It consists of the <i>LPL</i> Ser447Ter variant in an adeno-associated virus serotype 1 (alipogene tiparvovec). Twenty percent of the general population has the Ser447Ter allelic variant, which results in a prematurely truncated LPL that is associated with increased lipolytic function and an anti-atherogenic lipid profile and can therefore be regarded as a naturally occurring <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variant (reviewed by <a class="bk_pop" href="#lpl.REF.gaudet.2013.361">Gaudet et al [2013]</a>). Note that the standard nomenclature for this variant is <a href="https://www.ncbi.nlm.nih.gov/protein/NP_000228.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000228.1</a>:p.Ser474Ter (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000237.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000237.2</a>:c.1421C&#x0003e;G). Several other targeted therapies are in development or under investigation, including inhibitors of microsomal triglyceride transfer protein (MTP) [<a class="bk_pop" href="#lpl.REF.sacks.2014.443">Sacks et al 2014</a>], diacylglycerol acyl transferase 1 (DGAT1) [<a class="bk_pop" href="#lpl.REF.meyers.2015.8">Meyers et al 2015</a>], apoC-III [<a class="bk_pop" href="#lpl.REF.gaudet.2014.2200">Gaudet et al 2014</a>], and angiopoietin-like protein 3 (ANGPTL3) [<a class="bk_pop" href="#lpl.REF.gryn.2015.484">Gryn &#x00026; Hegele 2015</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="lpl.Other"><h3>Other</h3><p>The lipid-lowering drugs that are used to treat other disorders of lipid metabolism are not effective in individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency.</p><p>Although plasmapheresis and antioxidant therapy have been suggested as treatment for pancreatitis, they do not appear to be needed for either acute therapy or long-term care.</p></div></div><div id="lpl.Genetic_Counseling"><h2 id="_lpl_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="lpl.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Familial LPL deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="lpl.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>LPL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic but may have moderately elevated plasma triglyceride concentrations and may be at mild risk for premature atherosclerosis.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic but may have moderately elevated plasma triglyceride concentrations and may be at mild risk for premature atherosclerosis.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LPL</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>LPL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="lpl.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>LPL</i> pathogenic variants in the family. The lipid <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of heterozygotes varies widely from completely normal to moderate-to-severe hypertriglyceridemia and cannot be used to predict <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status.</p></div><div id="lpl.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See <a href="#lpl.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul></div><div id="lpl.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>LPL</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> LPL deficiency are possible.</p><p>Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate. In practice, prenatal testing is rarely requested because of the availability of effective treatment.</p></div></div><div id="lpl.Resources"><h2 id="_lpl_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial lipoprotein lipase deficiency</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=familiallipoproteinlipasedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial lipoprotein lipase deficiency</a></div></li></ul></div><div id="lpl.Molecular_Genetics"><h2 id="_lpl_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="lpl.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Familial Lipoprotein Lipase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1308/table/lpl.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lpl.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_lpl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_lpl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_lpl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_lpl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_lpl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_lpl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_lpl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4023" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LPL</i></a></td><td headers="hd_b_lpl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4023" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_lpl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P06858" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lipoprotein lipase</a></td><td headers="hd_b_lpl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/LPL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">lipoprotein lipase (LPL)</a></td><td headers="hd_b_lpl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LPL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LPL</a></td><td headers="hd_b_lpl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LPL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LPL</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="lpl.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="lpl.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Familial Lipoprotein Lipase Deficiency (<a href="/omim/238600,609708" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1308/table/lpl.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lpl.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/238600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">238600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPERLIPOPROTEINEMIA, TYPE I</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609708" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609708</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LIPOPROTEIN LIPASE; LPL</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>LPL</i> comprises ten exons; the last one encodes the long untranslated 3&#x02019;-end of the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000237.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000237.2</a>). The sequence of <i>LPL</i> is highly conserved among mammalian species.</p><p><b>Pathogenic variants.</b> More than 220 pathogenic variants have been identified [<a class="bk_pop" href="#lpl.REF.brunzell.2001">Brunzell &#x00026; Deeb 2001</a>, <a class="bk_pop" href="#lpl.REF.gilbert.2001.25">Gilbert et al 2001</a>]; see <a href="/books/NBK1308/#lpl.molgen.TA">Table A</a>, <b>HGMD</b>. Approximately 70% of these variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, 10% <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and 18% nucleotide insertions and deletions; a few <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants are also known. About 3% of pathogenic variants have an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or multiexon <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>, or complex rearrangement.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Lipoprotein lipase (LPL) is a glycoprotein that is synthesized in adipose tissue and cardiac and skeletal muscle, but not in the postpartum liver. It is transported to the luminal surface of the capillary endothelium of extrahepatic tissues. It is essential for the hydrolysis of chylomicron and VLDL triglycerides to provide free fatty acids to tissue for energy production. LPL has two major domains: a larger NH<sub>2</sub>-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> linked by a short region to a COOH-terminal domain of approximately half its size. The globular NH<sub>2</sub>-terminal domain specifies the catalytic properties of the lipase, whereas the COOH-terminal domain specifies substrate specificity and heparin-binding properties. <i>LPL</i> encodes a protein of 475 amino acids that becomes a mature protein of 448 residues after cleavage of a signal peptide (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000228.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000228.1</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic deletions and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants presumably lead to absent or truncated LPL with defective catalytic activity. Most of the variants are in the highly conserved central homology region [<a class="bk_pop" href="#lpl.REF.brunzell.2001">Brunzell &#x00026; Deeb 2001</a>, <a class="bk_pop" href="#lpl.REF.gilbert.2001.25">Gilbert et al 2001</a>]. Many <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants result in LPL deficiency secondary to LPL homodimer instability.</p></div><div id="lpl.References"><h2 id="_lpl_References_">References</h2><div id="lpl.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.alshali.2002.125">Al-Shali K, Wang J, Fellows F, Huff MW, Wolfe BM, Hegele RA. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. <span><span class="ref-journal">Clin Biochem. </span>2002;<span class="ref-vol">35</span>:125–30.</span> [<a href="/pubmed/11983347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11983347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.beigneux.2007.279">Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding ZM, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. <span><span class="ref-journal">Cell Metab. </span>2007;<span class="ref-vol">5</span>:279–91.</span> [<a href="/pmc/articles/PMC1913910/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1913910</span></a>] [<a href="/pubmed/17403372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17403372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.beigneux.2009.956">Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BS, Kuivenhoven JA, Kastelein JJ, Fong LG, Dallinga-Thie GM, Young SG. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. <span><span class="ref-journal">Arterioscler. Thromb. Vasc. Biol. </span>2009;<span class="ref-vol">29</span>:956–62.</span> [<a href="/pmc/articles/PMC2811263/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2811263</span></a>] [<a href="/pubmed/19304573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19304573</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.beigneux.2017.1647">Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charri&#x000e8;re S, Fong LG, Nakajima K, Young SG. Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia. <span><span class="ref-journal">N Engl J Med. </span>2017;<span class="ref-vol">376</span>:1647–58.</span> [<a href="/pmc/articles/PMC5555413/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5555413</span></a>] [<a href="/pubmed/28402248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28402248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.brahm.2015.352">Brahm AJ, Hegele RA. Chylomicronaemia&#x02013;current diagnosis and future therapies. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2015;<span class="ref-vol">11</span>:352–62.</span> [<a href="/pubmed/25732519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25732519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.brunzell.2001">Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo CII deficiency and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic and Molecular Bases of Inherited Disease.</em> 8 ed. New York, NY: McGraw-Hill; 2001:2789-816.</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.calandra.2006.122">Calandra S, Priore Oliva C, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. <span><span class="ref-journal">Curr. Opin. Lipidol. </span>2006;<span class="ref-vol">17</span>:122–7.</span> [<a href="/pubmed/16531747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16531747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.chait.1983.209">Chait A, Brunzell JD. Severe hypertriglyceridemia: role of familial and acquired disorders. <span><span class="ref-journal">Metabolism. </span>1983;<span class="ref-vol">32</span>:209–14.</span> [<a href="/pubmed/6827992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6827992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.chait.1981.343">Chait A, Robertson HT, Brunzell JD. Chylomicronemia syndrome in diabetes mellitus. <span><span class="ref-journal">Diabetes Care. </span>1981;<span class="ref-vol">4</span>:343–8.</span> [<a href="/pubmed/7344882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7344882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gaudet.2014.2200">Gaudet D, Brisson D, Tremblay K, Alexander VJ, Singleton W, Hughes SG, Geary RS, Baker BF, Graham MJ, Crooke RM, Witztum JL. Targeting APOC3 in the familial chylomicronemia syndrome. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:2200–6.</span> [<a href="/pubmed/25470695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25470695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gaudet.2013.361">Gaudet D, M&#x000e9;thot J, D&#x000e9;ry S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, Sier-Ferreira V, van Deventer S. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. <span><span class="ref-journal">Gene Ther. </span>2013;<span class="ref-vol">20</span>:361–9.</span> [<a href="/pmc/articles/PMC4956470/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4956470</span></a>] [<a href="/pubmed/22717743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22717743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gilbert.2001.25">Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P, Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75% are clustered in exons 5 and 6. <span><span class="ref-journal">Ann Genet. </span>2001;<span class="ref-vol">44</span>:25–32.</span> [<a href="/pubmed/11334614" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11334614</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gin.2012.2961">Gin P, Goulbourne CN, Adeyo O, Beigneux AP, Davies BS, Tat S, Voss CV, Bensadoun A, Fong LG, Young SG. Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:2961–72.</span> [<a href="/pmc/articles/PMC3373243/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3373243</span></a>] [<a href="/pubmed/22493000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22493000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gotoda.2012.1">Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N, et al.  Diagnosis and management of type I and type V hyperlipoproteinemia. <span><span class="ref-journal">J Atheroscler Thromb. </span>2012;<span class="ref-vol">19</span>:1–12.</span> [<a href="/pubmed/22129523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22129523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.gryn.2015.484">Gryn SE, Hegele RA. Novel therapeutics in hypertriglyceridemia. <span><span class="ref-journal">Curr Opin Lipidol. </span>2015;<span class="ref-vol">26</span>:484–91.</span> [<a href="/pubmed/26780002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26780002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.hegele.2014.655">Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Bor&#x000e9;n J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Stroes E, Taskinen MR, Tybj&#x000e6;rg-Hansen A, Watts GF, Wiklund O, et al.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. <span><span class="ref-journal">Lancet Diabetes Endocrinol. </span>2014;2014;<span class="ref-vol">2</span>:655–66.</span> [<a href="/pmc/articles/PMC4201123/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4201123</span></a>] [<a href="/pubmed/24731657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24731657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.heilman.1974.67">Heilman KM, Fisher WR. Hyperlipidemic dementia. <span><span class="ref-journal">Arch Neurol. </span>1974;<span class="ref-vol">31</span>:67–8.</span> [<a href="/pubmed/4834546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4834546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.jap.2003.122">Jap TS, Jenq SF, Wu YC, Chiu CY, Cheng HM. Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan. <span><span class="ref-journal">Pancreas. </span>2003;<span class="ref-vol">27</span>:122–6.</span> [<a href="/pubmed/12883259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12883259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.kawashiri.2005.6541">Kawashiri MA, Higashikata T, Mizuno M, Takata M, Katsuda S, Miwa K, Nozue T, Nohara A, Inazu A, Kobayashi J, Koizumi J, Mabuchi H. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:6541–4.</span> [<a href="/pubmed/16174715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16174715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.mart_ncampos.2014.61">Mart&#x000ed;n-Campos JM, Julve J, Roig R, Mart&#x000ed;nez S, Errico TL, Mart&#x000ed;nez-Couselo S, Escol&#x000e0;-Gil JC, M&#x000e9;ndez-Gonz&#x000e1;lez J, Blanco-Vaca F. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency. <span><span class="ref-journal">Clin Chim Acta. </span>2014;<span class="ref-vol">429</span>:61–8.</span> [<a href="/pubmed/24291057" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24291057</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.meyers.2015.8">Meyers CD, Tremblay K, Amer A, Chen J, Jiang L, Gaudet D. Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. <span><span class="ref-journal">Lipids Health Dis. </span>2015;<span class="ref-vol">14</span>:8.</span> [<a href="/pmc/articles/PMC4337059/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4337059</span></a>] [<a href="/pubmed/25889044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25889044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.murthy.1996.101">Murthy V, Julien P, Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. <span><span class="ref-journal">Pharmacol Ther. </span>1996;<span class="ref-vol">70</span>:101–35.</span> [<a href="/pubmed/8843465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8843465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.nilsson.2011.15">Nilsson SK, Heeren J, Olivecrona G, Merkel M. Apolipoprotein A-V; a potent triglyceride reducer. <span><span class="ref-journal">Atherosclerosis. </span>2011;<span class="ref-vol">219</span>:15–21.</span> [<a href="/pubmed/21831376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21831376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.okubo.2015.148">Okubo M, Toromanovic A, Ebara T, Murase T. Apolipoprotein C-II: a novel large deletion in APOC2 caused by Alu&#x02013;Alu homologous recombination in an infant with apolipoprotein C-II deficiency. <span><span class="ref-journal">Clin Chim Acta. </span>2015;<span class="ref-vol">438</span>:148–53.</span> [<a href="/pubmed/25172036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25172036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.p_terfy.2012.790">P&#x000e9;terfy M. Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism. <span><span class="ref-journal">Biochim Biophys Acta. </span>2012;<span class="ref-vol">1821</span>:790–4.</span> [<a href="/pmc/articles/PMC3288453/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3288453</span></a>] [<a href="/pubmed/22063272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22063272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.p_terfy.2007.1483">P&#x000e9;terfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR, Frost PH, Kane JP, Malloy MJ, Reue K, Pajukanta P, Doolittle MH. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1483–7.</span> [<a href="/pubmed/17994020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17994020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.sacks.2014.443">Sacks FM, Stanesa M, Hegele RA. Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide. <span><span class="ref-journal">JAMA Intern Med. </span>2014;<span class="ref-vol">174</span>:443–7.</span> [<a href="/pubmed/24366202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24366202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.stroes.2017.1">Stroes E, Moulin P, Parhofer KG, Rebours V, L&#x004e7;hr JM, Averna M. Diagnostic algorithm for familial chylomicronemia syndrome. <span><span class="ref-journal">Atheroscler Suppl. </span>2017;<span class="ref-vol">23</span>:1–7.</span> [<a href="/pubmed/27998715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27998715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.tsai.2004.27">Tsai EC, Brown JA, Veldee MY, Anderson GJ, Chait A, Brunzell JD. Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report. <span><span class="ref-journal">BMC Pregnancy Childbirth. </span>2004;<span class="ref-vol">4</span>:27.</span> [<a href="/pmc/articles/PMC544881/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC544881</span></a>] [<a href="/pubmed/15610556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15610556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lpl.REF.viljoen.2012.505">Viljoen A, Wierzbicki AS. Diagnosis and treatment of severe hypertriglyceridemia. <span><span class="ref-journal">Expert Rev Cardiovasc Ther. </span>2012;<span class="ref-vol">10</span>:505–14.</span> [<a href="/pubmed/22458582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22458582</span></a>]</div></li></ul></div></div><div id="lpl.Chapter_Notes"><h2 id="_lpl_Chapter_Notes_">Chapter Notes</h2><div id="lpl.Author_History"><h3>Author History</h3><p>John D Brunzell, MD; University of Washington (1999-2017)<br />John R Burnett, MB ChB, MD, PhD, FRCPA (2017-present)<br />Robert A Hegele, MD, FRCPC, FACP (2017-present)<br />Amanda J Hooper, PhD (2017-present)</p></div><div id="lpl.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 June 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 December 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 July 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available; prenatal testing available; mutation analysis for p.Gly188Glu done by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a></div></li><li class="half_rhythm"><div>24 April 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 April 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 February 2002 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 October 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>April 1999 (jb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1308</span><span class="label">PMID: <a href="/pubmed/20301485" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301485</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fmf/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1308&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1308/?report=reader">PubReader</a></li><li><a href="/books/NBK1308/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1308" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1308" style="display:none" title="Cite this Page"><div class="bk_tt">Burnett JR, Hooper AJ, Hegele RA. Familial Lipoprotein Lipase Deficiency. 1999 Oct 12 [Updated 2017 Jun 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1308/pdf/Bookshelf_NBK1308.pdf">PDF version of this page</a> (427K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#lpl.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#lpl.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#lpl.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#lpl.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#lpl.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#lpl.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#lpl.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#lpl.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#lpl.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#lpl.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#lpl.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4023[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LPL</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1466800" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1466800" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1466800" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1466800" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301360" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saheki T, Song YZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301631" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301677" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phenylalanine Hydroxylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phenylalanine Hydroxylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Regier DS, Greene CL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30358967" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett JR, Hooper AJ, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301485" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301485" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04159839a66ee2ba0c1838">Familial Lipoprotein Lipase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Familial Lipoprotein Lipase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:06:16-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AE69CE040F0F10000000002D90101&amp;ncbi_session=CE8AE69CE0415971_0729SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1308%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1308&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1308/&amp;ncbi_pagename=Familial Lipoprotein Lipase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AE69CE0415971_0729SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>